ArticleInternational journal of ophthalmology2021

Efficacy and safety of newly developed preservative-free latanoprost 0.005% eye drops versus preserved latanoprost 0.005% in open angle glaucoma and ocular hypertension: 12-week results of a randomized, multicenter, controlled phase III trial.

Joon Mo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.